๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Carcinoma, Non-Small-Cell Lung (NSCLC)

A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC NCT06754644Phase 31 site๐Ÿ“ Jinan Qilu Pharmaceutical Co., Ltd. ยท Tests: QL2107, Pemetrexed, Carboplatin, Keytrudaยฎ Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer๏ผˆNSCLC๏ผ‰ NCT07388771n/a2 sites๐Ÿ“ Wuhan๐Ÿ“ Hangzhou Qian Chu A Real World Study of Ensartinib in Advanced ALK-positive NSCLC NCT05498064n/a1 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Ensartinib Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation NCT05010109NA1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: 6 Minute Walk Functional Test, Biospecimen Collection, Computed Tomography, Echocardiography, Exercise Cardiac Stress Tโ€ฆ A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC NCT06424899Phase 21 site๐Ÿ“ Hangzhou Zeng Jian ยท Tests: Adebrelimab, radical chemoradiotherapy, Platinum based chemotherapy Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung) NCT07120698Phase 22 sites๐Ÿ“ Guangzhou๐Ÿ“ Chengdu Guangdong Association of Clinical Trials ยท Tests: Sintilimab Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC NCT06162221Phase 1, Phase 298 sites๐Ÿ“ Gilbert๐Ÿ“ Duarte๐Ÿ“ Irvine Revolution Medicines, Inc. ยท Tests: RMC-6291, RMC-6236, Pembrolizumab, Cisplatin, Carboplatin Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites๐Ÿ“ Los Angeles๐Ÿ“ New Haven๐Ÿ“ New Haven Pfizer ยท Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors NCT06107608NA1 site๐Ÿ“ Brussels Jules Bordet Institute ยท Tests: FAPI PET/CT TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients NCT06455917Phase 21 site๐Ÿ“ Basel University Hospital, Basel, Switzerland ยท Tests: TILs๏ผˆTumor Infiltrating Lymphocytes๏ผ‰ ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs NCT06775743Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: ORIENT-31 regimen, SBRT To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer NCT07195084NA1 site๐Ÿ“ Hefei Anhui Provincial Cancer Hospital ยท Tests: Hypervision proton surgery A Study of JMT203 in Patients With Cancer Cachexia NCT06868849Phase 1, Phase 21 site๐Ÿ“ Zhejiang Shanghai JMT-Bio Inc. ยท Tests: JMT203 Injection, JMT203 Injection A Phase I Study of CFT8919 in Patients With Advanced NSCLC NCT06641609Phase 11 site๐Ÿ“ Hangzhou Betta Pharmaceuticals Co., Ltd. ยท Tests: Dose-Escalation (Phase Ia) CFT8919 capsule, Dose-Expansion (Phase Ib) CFT8919 capsule, Cohort-Expansion (Phase Ic) CFT8โ€ฆ Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients NCT06634199n/a22 sites๐Ÿ“ Ferrol๐Ÿ“ Alicante๐Ÿ“ Badalona Fundaciรณn GECP ยท Tests: Durvalumab The Effect of Beta-glucan in Non-Small Cell Lung Cancer NCT00682032NA1 site๐Ÿ“ Louisville University of Louisville ยท Tests: beta-glucan Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer NCT06926179n/a4 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Hohhot Peking University Cancer Hospital & Institute ยท Tests: neoadjuvant immunotherapy A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation. NCT05967689Phase 280 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Boston Taiho Oncology, Inc. ยท Tests: TAS6417, CYP Cocktail, Transporter Cocktail Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) NCT07761910Phase 21 site๐Ÿ“ Indianapolis Indiana University ยท Tests: PET/CT 18F-Flurpiridaz Rest/Stress Test, Coronary CT Angiography (CCTA), 18F-Flurpiridaz Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer NCT06833632n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases NCT05033691NA1 site๐Ÿ“ Jerusalem Hadassah Medical Organization ยท Tests: Stereotactic surgery Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC NCT06878274Phase 21 site๐Ÿ“ Montreal Centre hospitalier de l'Universitรฉ de Montrรฉal (CHUM) ยท Tests: Post-operative radiotherapy A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Birmingham Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046054, pembrolizumab Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer NCT00897117n/a3 sites๐Ÿ“ Nashville๐Ÿ“ Nashville๐Ÿ“ Nashville Vanderbilt-Ingram Cancer Center ยท Tests: gene expression analysis, microarray analysis, protein expression analysis, biologic sample preservation procedure, labโ€ฆ A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) NCT06452277Phase 3279 sites๐Ÿ“ Newport Beach๐Ÿ“ San Diego๐Ÿ“ San Francisco Bayer ยท Tests: Sevabertinib, Pembrolizumab, Cisplatin, Carboplatin, Pemetrexed Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer NCT07288177Phase 291 sites๐Ÿ“ Fountain Valley๐Ÿ“ Irvine๐Ÿ“ San Diego Genmab ยท Tests: Rina-S GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer NCT07017829Phase 21 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Anti-CFH Monoclonal Antibody GT103, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ Stanford BioEclipse Therapeutics ยท Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide A Phase Ib Study of GC101 in NSCLC NCT06473961Phase 11 site๐Ÿ“ Shanghai Shanghai Juncell Therapeutics ยท Tests: Autologous Tumor Infiltrating Lymphocytes TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites๐Ÿ“ London๐Ÿ“ Manchester๐Ÿ“ Southampton Cancer Research UK ยท Tests: TT-702, Anti-PD-1 and PD-L1 agent
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy